Live Breaking News & Updates on National organ program

Stay updated with breaking news from National organ program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TransMedics Stock Skyrockets, Analysts Call It 'One Of The Best Organic Growth Stories' - TransMedics Gr (NASDAQ:TMDX)

TransMedics shines with Q1 EPS at $0.35, and sales soared to $96.9 million. Fiscal 2024 revenue outlook raised to $390 million-$400 million. Analysts hail TransMedics' organic growth and strong market position, praising its innovative solutions and promising prospects.

William-blair , National-organ-program , International-society-for-heart , Transmedics-group-inc , Transmedics-group , Organ-care-system , International-society , Lung-transplantation ,

Why Is TransMedics Stock Trading Higher Today? - TransMedics Gr (NASDAQ:TMDX)

TransMedics jumps with 159% YoY Q4 2023 revenue surge to $81.2 million. Analysts upbeat on strategic growth, price target raised to $105.

Waleed-hassanein , William-blair , National-organ-program , Transmedics-group-inc , Transmedics-group , Organ-care-system , Chief-executive , Brain-death ,